Combretastatin
- Generic Name
- Combretastatin
- Drug Type
- Small Molecule
- Chemical Formula
- C18H22O6
- CAS Number
- 82855-09-2
- Unique Ingredient Identifier
- 7O62J06F18
Overview
Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Background
Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath